التركيز الثابت في الحالة الساكنة

Steady-state concentration (Css) is the point where drug administration and elimination rates are equal, maintaining constant plasma concentration over time. This dynamic equilibrium produces the desired clinical effect while minimizing toxicity. All dosing regimens aim to maintain steady-state concentration to ensure the most effective therapeutic response with the least risk of adverse effects.

Most drugs attain steady state within four to five half-lives. During a continuous IV infusion, it takes one half-life to reach 50% of Css, two half-lives to reach 75%, and nearly three half-lives to reach 90%. The rate at which steady state is achieved depends directly on the drug's half-life, which is the time required to clear 50% of the drug from the body.

Most dosage regimens use repeated doses at fixed intervals or continuous IV infusions to achieve steady-state concentration. After each dose, the drug is absorbed, distributed, metabolized, and eliminated. As subsequent doses are administered, drug accumulates until the amount eliminated in each dosing interval matches the amount administered, establishing stable concentration within a predictable therapeutic range.

Once steady state is achieved, the drug's concentration fluctuates within a narrow therapeutic range, ensuring consistent pharmacological effect. The drug concentration remains relatively constant over time because the administration rate equals the elimination rate. This stable concentration prevents suboptimal treatment and reduces the risk of adverse effects from toxicity.

A drug's half-life directly determines how quickly steady state is achieved. Drugs with shorter half-lives reach steady state faster, while drugs with longer half-lives take proportionally more time. Since most drugs require four to five half-lives to attain steady state, understanding a drug's half-life is essential for predicting when therapeutic levels will be maintained.

Patient characteristics, drug interactions, and changes in drug clearance significantly influence the ability to achieve and maintain steady state. Deviations from steady-state concentration may lead to suboptimal treatment or increased risk of adverse effects. Healthcare providers must account for individual patient factors when selecting dosing strategies to ensure the drug remains within the therapeutic range.

Steady state represents a dynamic equilibrium where the drug administration rate exactly equals the drug elimination rate. When these rates are balanced, plasma concentration remains constant, producing reliable therapeutic effects. If administration exceeds elimination, drug accumulates and toxicity risk increases; if elimination exceeds administration, concentration falls below therapeutic levels.